Ikarian Capital, LLC
Filing Date
Global Rank
#1,670
/ 8,603
▲ 149
· as of Mar 2026
Top Industry
Biotechnology
88.9%
3Y Alpha vs SPY
+10.7%
Period ended 3 months ago
Filed May 15, 2026 · 55d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+125.1%
SPY
+76.5%
Annualised alpha
+10.2%
Max drawdown
−44.9%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
134 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
12.8%
+4.7 pts
Top 5
34.0%
+8.5 pts
Top 10
46.8%
+7.8 pts
HHI
374
Diversified+119
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 94.4% | $1,029,514,852 |
| Unclassified | 5.3% | $57,718,000 |
| Financial Services | 0.3% | $2,795,937 |
| Industrials | 0.0% | $73,101 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| OVID | Ovid Therapeutics Inc. | +2,647,146 | 2,894,704 | $6,426,242 | |
| KPTI | Karyopharm Therapeutics Inc. | +2,028,881 | 2,573,435 | $14,334,032 | |
| ALMS | Alumis Inc. | +1,267,048 | 1,478,148 | $32,563,600 | |
| TERN | Terns Pharmaceuticals, Inc. | +1,060,000 | 2,656,378 | $140,044,248 | |
| IVA | Inventiva S.A. | +926,500 | 1,429,101 | $7,931,510 | |
| ABOS | Acumen Pharmaceuticals, Inc. | +799,485 | 1,053,797 | $2,486,960 | |
| CYTK | Cytokinetics Inc | +778,900 | 1,242,472 | $81,891,329 | |
| KOD | Kodiak Sciences Inc. | +646,008 | 1,365,795 | $52,064,105 | |
| EPRX | Eupraxia Pharmaceuticals Inc. | +604,741 | 1,214,741 | $8,794,724 | |
| CNTB | Connect Biopharma Holdings Ltd | +600,000 | 5,533,086 | $14,496,685 | |
| CTNM | Contineum Therapeutics, Inc. | +525,000 | 807,874 | $10,550,834 | |
| AVTX | Avalo Therapeutics, Inc. | +470,794 | 560,000 | $8,360,800 | |
| ZURA | Zura Bio Ltd | +391,170 | 1,193,492 | $7,101,277 | |
| ANNX | Annexon, Inc. | +350,000 | 580,244 | $3,214,551 | |
| LPCN | Lipocine Inc. | +309,014 | 508,556 | $4,063,362 | |
| CAPR | Capricor Therapeutics, Inc. | +300,000 | 878,015 | $26,691,656 | |
| CMPS | COMPASS Pathways plc | +275,000 | 675,000 | $3,732,750 | |
| ANIP | Ani Pharmaceuticals Inc | +214,285 | 297,085 | $22,845,836 | |
| JBIO | Jade Biosciences, Inc. | +212,349 | 512,349 | $7,198,503 | |
| BHVN | Biohaven Ltd. | +200,000 | 412,481 | $3,489,589 | |
| OLMA | Olema Pharmaceuticals, Inc. | +189,427 | 1,148,081 | $17,117,887 | |
| TENX | Tenax Therapeutics, Inc. | +164,300 | 1,131,900 | $18,099,081 | |
| SRZN | Surrozen, Inc./DE | +107,319 | 173,107 | $5,042,606 | |
| PCVX | Vaxcyte, Inc. | +50,000 | 428,682 | $24,910,711 | |
| DMRA | Damora Therapeutics, Inc. | +50,000 | 335,710 | $8,694,889 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
18 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | −782,000 | 18,000 | $95,220 | |
| RLMD | Relmada Therapeutics, Inc. | −380,000 | 2,688,359 | $18,710,978 | |
| FULC | Fulcrum Therapeutics, Inc. | −326,311 | 1,049,161 | $8,047,064 | |
| SLDB | Solid Biosciences Inc. | −320,000 | 264,409 | $1,903,744 | |
| VIR | Vir Biotechnology, Inc. | −282,454 | 293,258 | $2,627,591 | |
| SLNO | Soleno Therapeutics Inc | −253,600 | 344,123 | $11,521,238 | |
| MAZE | Maze Therapeutics, Inc. | −251,281 | 393,399 | $11,742,960 | |
| FBRX | Forte Biosciences, Inc. | −181,028 | 118,972 | $3,081,374 | |
| HROW | Harrow, Inc. | −150,000 | 543,047 | $19,147,837 | |
| JAZZ | Jazz Pharmaceuticals plc | −147,907 | 12,460 | $2,355,563 | |
| IONS | Ionis Pharmaceuticals Inc | −57,500 | 239,138 | $17,956,872 | |
| NUVL | Nuvalent, Inc. | −36,000 | 23,594 | $2,417,205 | |
| RARE | Ultragenyx Pharmaceutical Inc. | −35,200 | 482,571 | $10,109,862 | |
| FTH | Faeth Therapeutics, Inc. | −15,000 | 6,351 | $200,183 | |
| PRAX | Praxis Precision Medicines, Inc. | −15,000 | 71,581 | $23,062,682 | |
| INSM | INSMED Inc | −13,723 | 4,214 | $689,073 | |
| LLY | ELI LILLY & Co | −7,268 | 6,547 | $6,021,734 | |
| CPIX | Cumberland Pharmaceuticals Inc | −2,779 | 553,153 | $1,797,747 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
23 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| QQQ | Invesco Qqq Trust, Series 1 | 100,000 | $57,718,000 | |
| BMY | Bristol Myers Squibb Co | 500,000 | $30,325,000 | |
| CLDX | Celldex Therapeutics, Inc. | 575,247 | $18,246,834 | |
| BBIO | BridgeBio Pharma, Inc. | 218,620 | $16,234,721 | |
| NVO | Novo Nordisk A S | 400,000 | $14,700,000 | |
| ORKA | Oruka Therapeutics, Inc. | 242,021 | $11,871,130 | |
| VERA | Vera Therapeutics, Inc. | 271,700 | $10,930,491 | |
| EYPT | EyePoint, Inc. | 740,800 | $9,548,912 | |
| PVLA | Palvella Therapeutics, Inc. | 64,626 | $8,055,630 | |
| OCGN | Ocugen, Inc. | 3,962,972 | $7,172,979 | |
| TECX | Tectonic Therapeutic, Inc. | 157,537 | $4,869,468 | |
| KYMR | Kymera Therapeutics, Inc. | 50,400 | $4,197,816 | |
| CRDL | Cardiol Therapeutics Inc. | 2,725,000 | $3,678,750 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 57,500 | $3,605,250 | |
| ELVN | Enliven Therapeutics, Inc. | 83,700 | $3,281,040 | |
| REPL | Replimune Group, Inc. | 300,000 | $2,295,000 | |
| AVR | Anteris Technologies Global Corp. | 366,571 | $2,034,469 | |
| DFTX | Definium Therapeutics, Inc. | 58,803 | $1,111,376 | |
| CNTA | Centessa Pharmaceuticals plc | 18,113 | $719,448 | |
| PMN | ProMIS Neurosciences Inc. | 55,000 | $698,500 | |
| ACAD | Acadia Pharmaceuticals Inc | 28,099 | $625,483 | |
| PASG | Passage BIO, Inc. | 68,124 | $534,773 | |
| ANL | Adlai Nortye Ltd. | 33,899 | $234,581 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AMGN | Amgen Inc | 245,000 | $80,190,950 | |
| OMER | Omeros Corp | 1,500,000 | $25,770,000 | |
| CORT | Corcept Therapeutics Inc | 586,093 | $20,396,036 | |
| CRNX | Crinetics Pharmaceuticals, Inc. | 368,500 | $17,153,675 | |
| NBIX | Neurocrine Biosciences Inc | 105,062 | $14,900,943 | |
| CTMX | CytomX Therapeutics, Inc. | 3,172,616 | $13,515,344 | |
| CELC | Celcuity Inc. | 105,545 | $10,527,058 | |
| APLS | Apellis Pharmaceuticals, Inc. | 397,347 | $9,981,356 | |
| DXCM | Dexcom Inc | 137,500 | $9,125,875 | |
| PTCT | Ptc Therapeutics, Inc. | 118,657 | $9,013,185 | |
| CGON | CG Oncology, Inc. | 199,473 | $8,282,118 | |
| MLYS | Mineralys Therapeutics, Inc. | 200,000 | $7,258,000 | |
| AGIO | Agios Pharmaceuticals, Inc. | 252,689 | $6,878,194 | |
| ADMA | Adma Biologics, Inc. | 234,854 | $4,283,736 | |
| KRYS | Krystal Biotech, Inc. | 14,814 | $3,652,243 | |
| TGTX | Tg Therapeutics, Inc. | 117,903 | $3,514,688 | |
| ZBIO | Zenas BioPharma, Inc. | 93,600 | $3,398,616 | |
| AQST | Aquestive Therapeutics, Inc. | 500,000 | $3,230,000 | |
| GOSS | Gossamer Bio, Inc. | 1,000,000 | $3,100,000 | |
| NKTR | Nektar Therapeutics | 72,600 | $3,069,528 | |
| ERAS | Erasca, Inc. | 735,396 | $2,735,673 | |
| NAMS | NewAmsterdam Pharma Co N.V. | 45,830 | $1,607,716 | |
| TVTX | Travere Therapeutics, Inc. | 36,600 | $1,398,486 | |
| CPRX | Catalyst Pharmaceuticals, Inc. | 57,388 | $1,339,435 | |
| GPCR | Structure Therapeutics Inc. | 4,824 | $335,509 | |
| No positions match the current search. | ||||
134 positions ·
$1,090,101,890 total
· as of Mar 31, 2026
Showing 1–50
of 134 positions by value
· page 1 of 3
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Added | 2,656,378 | $140,044,248 | 12.85% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Added | 1,242,472 | $81,891,329 | 7.51% | |
| QQQ |
Invesco Qqq Trust, Series 1
|
NEW | 100,000 | $57,718,000 | 5.29% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
Added | 1,365,795 | $52,064,105 | 4.78% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 350,935 | $39,076,612 | 3.58% | |
| ALMS |
Alumis Inc.
Healthcare
|
Added | 1,478,148 | $32,563,600 | 2.99% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
NEW | 500,000 | $30,325,000 | 2.78% | |
| CAPR |
Capricor Therapeutics, Inc.
Healthcare
|
Added | 878,015 | $26,691,656 | 2.45% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 258,142 | $25,104,309 | 2.30% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Added | 428,682 | $24,910,711 | 2.29% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Reduced | 71,581 | $23,062,682 | 2.12% | |
| ANIP |
Ani Pharmaceuticals Inc
Healthcare
|
Added | 297,085 | $22,845,836 | 2.10% | |
| HROW |
Harrow, Inc.
Healthcare
|
Reduced | 543,047 | $19,147,837 | 1.76% | |
| RLMD |
Relmada Therapeutics, Inc.
Healthcare
|
Reduced | 2,688,359 | $18,710,978 | 1.72% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
NEW | 575,247 | $18,246,834 | 1.67% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
Added | 1,131,900 | $18,099,081 | 1.66% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Reduced | 239,138 | $17,956,872 | 1.65% | |
| OLMA |
Olema Pharmaceuticals, Inc.
Healthcare
|
Added | 1,148,081 | $17,117,887 | 1.57% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
NEW | 218,620 | $16,234,721 | 1.49% | |
| NVO |
Novo Nordisk A S
Healthcare
|
NEW | 400,000 | $14,700,000 | 1.35% | |
| CNTB |
Connect Biopharma Holdings Ltd
Healthcare
|
Added | 5,533,086 | $14,496,685 | 1.33% | |
| KPTI |
Karyopharm Therapeutics Inc.
Healthcare
|
Added | 2,573,435 | $14,334,032 | 1.31% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Held | 486,856 | $13,753,682 | 1.26% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Added | 166,647 | $12,160,231 | 1.12% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
NEW | 242,021 | $11,871,130 | 1.09% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
Reduced | 393,399 | $11,742,960 | 1.08% | |
| ANRO |
Alto Neuroscience, Inc.
Healthcare
|
Held | 515,000 | $11,577,200 | 1.06% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Reduced | 344,123 | $11,521,238 | 1.06% | |
| DBVT |
DBV Technologies S.A.
Healthcare
|
Held | 525,000 | $10,967,250 | 1.01% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
NEW | 271,700 | $10,930,491 | 1.00% | |
| CTNM |
Contineum Therapeutics, Inc.
Healthcare
|
Added | 807,874 | $10,550,834 | 0.97% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Reduced | 482,571 | $10,109,862 | 0.93% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
NEW | 740,800 | $9,548,912 | 0.88% | |
| EPRX |
Eupraxia Pharmaceuticals Inc.
Healthcare
|
Added | 1,214,741 | $8,794,724 | 0.81% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
Added | 335,710 | $8,694,889 | 0.80% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Added | 560,000 | $8,360,800 | 0.77% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
NEW | 64,626 | $8,055,630 | 0.74% | |
| FULC |
Fulcrum Therapeutics, Inc.
Healthcare
|
Reduced | 1,049,161 | $8,047,064 | 0.74% | |
| IVA |
Inventiva S.A.
Healthcare
|
Added | 1,429,101 | $7,931,510 | 0.73% | |
| SPRB |
Spruce Biosciences, Inc.
Healthcare
|
Held | 121,356 | $7,930,614 | 0.73% | |
| IMUX |
Immunic, Inc.
Healthcare
|
Held | 674,662 | $7,488,748 | 0.69% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
Added | 512,349 | $7,198,503 | 0.66% | |
| OCGN |
Ocugen, Inc.
Healthcare
|
NEW | 3,962,972 | $7,172,979 | 0.66% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
Added | 1,193,492 | $7,101,277 | 0.65% | |
| OVID |
Ovid Therapeutics Inc.
Healthcare
|
Added | 2,894,704 | $6,426,242 | 0.59% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 6,547 | $6,021,734 | 0.55% | |
| ACOG |
Alpha Cognition Inc.
Healthcare
|
Held | 1,056,259 | $5,798,861 | 0.53% | |
| PTHS |
Pelthos Therapeutics Inc.
Healthcare
|
Reduced | 256,598 | $5,391,123 | 0.49% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
Added | 173,107 | $5,042,606 | 0.46% | |
| TECX |
Tectonic Therapeutic, Inc.
Healthcare
|
NEW | 157,537 | $4,869,468 | 0.45% |